Panakeia ("the Company"), the world's first in silico multi-omics company, today unveiled landmark pathway activation data in cancers at the American Association for Cancer Research (AACR) Annual ...
The treatment landscape of generalised myasthenia gravis, a prototypic antibody-mediated disorder of the neuromuscular junction, has considerably evolved in the past 8 years.1 The approval of targeted ...
Therapeutic fasting offers a metabolic approach to chronic pain by shifting to fat metabolism, reducing systemic inflammation ...
NIQ (NYSE: NIQ), a leading consumer intelligence company, and Stirista, a provider of identity-driven marketing solutions, ...
Revolution Medicines, Inc. (Nasdaq: RVMD), a late-stage clinical oncology company developing targeted therapies for patients with RAS-addicted cancers, today announced preclinical data highlighting an ...
Systemic lupus erythematosus (SLE) involves ongoing inflammation, tissue damage from immune complexes, and incomplete immune resolution. A key factor ...
Olverembatinib, an investigational multikinase inhibitor (approved in China for CML), inhibits Src-family kinases (e.g., Lyn, ...
It’s ancient, unstoppable and strangely contagious. Here’s what science now knows about the humble yawn, and why evolution ...
When an axolotl loses a limb to a hungry predator, it sprouts a structurally sound replacement, rebuilding flesh, bone, and ...
Attention is a physical experience, and the channels that respect that reality will always command deeper engagement.
Indonesian cosmetics group Wardah has appointed Al Qubaisi as its global ambassador, for its “Own Your Finish” campaign ...
If your immune system overreacts to pollen or other allergens, a diet rich in compounds that boost immune health and reduce ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results